Fiche d'information compilée à partir de PubMed
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 30 articles PubMed · modèle : gemma4:31b
Résumé
Contexte
Usages traditionnels
Composés actifs
Mécanisme d'action
Preuves cliniques
Extracts of A. purpurata were proven to be alternative solutions for treating C. krusei resistance [PMID:37898844]
Leaf subextracts demonstrated in vitro inhibitory activity against M. tuberculosis [PMID:21120040]
Ethyl acetate leaf extract showed potential anticancer activity with a half maximal inhibitory concentration (IC50) of 110.25 μg/mL at 48 hours [PMID:23257141]
The lectin ApuL showed bacteriostatic activity against S. aureus and fungistatic effects against C. albicans and C. parapsilosis [PMID:30142463]
Kumatakenin significantly alleviated symptoms and suppressed intestinal inflammation by inhibiting ferroptosis [PMID:37006994]
Synthèse des preuves
Sources PubMed
- 1.PMID: 26559362 (2015) — Phytochemistry and pharmacology of ornamental gingers, Hedychium coronarium and Alpinia purpurata: a review. · Journal of integrative medicine
- 2.PMID: 27038825 (2016) — Deep sequencing of banana bract mosaic virus from flowering ginger (Alpinia purpurata) and development of an immunocapture RT-LAMP detection assay. · Archives of virology
- 3.PMID: 37898844 (2023) — The Antifungal Activities of Syzygium aromaticum and Alpinia purpurata Extracts Against Candida krusei: Bioactivity Tests, Molecular Modeling, and Toxicity Tests. · Asian Pacific journal of cancer prevention : APJCP
- 4.PMID: 21120040 (2010) — Phytoconstituents from Alpinia purpurata and their in vitro inhibitory activity against Mycobacterium tuberculosis. · Pharmacognosy magazine
- 5.PMID: 25141816